论文信息 - Nutritional Genomics

Nutritional Genomics

Nutritional genomics is the science which study about the relationship between genome, nutrition, health and diseases. Principles of this science are based on the facts that the diet of a person interferes with the genetic makeup; thus by regulating the diet, certain diseases can be prevented or controlled. Dietary chemicals can affect gene expression directly or indirectly. A subset of genes regulated by diet must be involved in certain disease initiation, progression, and severity. Dietary intervention based on knowledge of nutritional requirement, nutritional status, and genotype can be used to prevent, mitigate, or cure chronic disease. It also studies about how individual differences in genes influence the body's response to diet. The study aims to harness the information contained in human genomes to achieve successful production and health.

S. M | S. M

[1] S. Ross. Nutritional genomic approaches to cancer prevention research. , 2007, Experimental oncology.

[2] J. Frank. Diagnosis and management of G6PD deficiency. , 2005, American family physician.

[3] P. Kantoff,et al. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. , 2005, Cancer research.

[4] J. Milner,et al. Molecular targets for bioactive food components. , 2004, The Journal of nutrition.

[5] R. Rodriguez,et al. Nutritional genomics: the next frontier in the postgenomic era. , 2004, Physiological genomics.

[6] S. Christ. Asbjørn Følling and the Discovery of Phenylketonuria , 2003, Journal of the history of the neurosciences.

[7] G. Sonenshein,et al. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. , 2002, Cancer research.

[8] H. Ahn,et al. Green tea compounds inhibit tyrosine phosphorylation of PDGF β‐receptor and transformation of A172 human glioblastoma , 2000, FEBS letters.

[9] T. Ueno,et al. Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90. , 2004, Journal of hepatology.